Genotype-phenotype relationship in inflammatory bowel disease

European Journal of Internal Medicine

Volumn 11, Issue 4, 2000, Pages 204-209

  Pera, Angelo ^a   Sostegni, Raffaello ^a   Daperno, Marco ^a   Ercole, Elena ^a   Laudi, Cristiana ^a   Rocca, Rodolfo ^a   Rigazio, Caterina ^a   Astegiano, Marco ^b   Rocca, Giuseppe ^b  

^a MAURIZIANO HOSPITAL   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

Author keywords

Chromosome 12; Chromosome 16; Clinical classifications; Clinical presentation; Familial aggregation; HLA linkage

Indexed keywords

AZATHIOPRINE; NEUTROPHIL CYTOPLASMIC ANTIBODY; STEROID;

ADULT; CHROMOSOME 12; CHROMOSOME 16; CLINICAL FEATURE; CROHN DISEASE; DISEASE ASSOCIATION; ENTERITIS; FAMILY HISTORY; GENOTYPE; HLA TYPING; HUMAN; MAJOR CLINICAL STUDY; PHENOTYPE; REVIEW; ULCERATIVE COLITIS;

EID: 0033858767     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0953-6205(00)00092-3     Document Type: Review

References (49)

1. Orholm M., Munkholm P., Langholz E., Nielsen O.H., Sorensen T.I.A., Binder V. Familial occurrence of inflammatory bowel disease. New Eng J Med. 324:1991;84-88.
2. Satsangi J., Jewell D.P., Bell J.I. The genetics of inflammatory bowel disease. Gut. 40:1997;572-574.
3. Rotter J.I., Yang H. Genetics of inflammatory bowel disease. Targan S.R., Sahan F. Inflammatory bowel disease: from the bench to the bedside. 1994;32-64 Williams & Wilkins, Baltimore. chapter 3.
4. Meucci G., Vecchi M., Torgano G., Arrigoni M., Prada A., Rocca F., Curzio M., Pera A., de Franchis R. Familial aggregation of inflammatory bowel disease in northern Italy: a multicenter study. The Gruppo di Studio per le Malattie Infiammatorie Intestinali (IBD Study Group). Gastroenterology. 103:(2):1992;514-519.
5. Reed J.F., Calkins B.M., Rosen L. Concordance of familial characteristics in Crohn's disease and ulcerative colitis. Dis Colon Rectum. 35:(5):1992;405-410.
6. Lee J.C., Lennard-Jones J.E. Inflammatory bowel disease in 67 families each with three or more affected first-degree relatives. Gastroenterology. 111:(3):1996;587-596.
7. Satsangi J., Grootscholten C., Holt H., Jewell D.P. Clinical patterns of familial inflammatory bowel disease. Gut. 38:(5):1996;738-741.
8. Annese V., Latiano A., Bovio P., Forabosco P., Piepoli A., Lombardi G., Andreoli A., Astegiano M., Gionchetti P., Riegler G., Sturniolo G.C., Clementi M., Rappaport E., Fortina P., Devoto M., Gasparini P., Andriulli A. Genetic analysis in Italian families with inflammatory bowel disease supports linkage to the IBD1 locus - a GISC study. Eur J Hum Genet. 7:(5):1999;567-573.
9. Peeters M., Nevens H., Baert F., Hiele M., de Meyer A.M., Vlietinck R., Rutgeerts P. Familial aggregation in Crohn's disease: increased age-adjusted risk and concordance in clinical characteristics. Gastroenterology. 111:(3):1996;597-603.
10. Heresbach D., Gulwani-Akolkar B., Lesser M., Akolkar P.N., Lin X.Y., Heresbach-Le Berre N., Bretagne J.F., Katz S., Silver J. Anticipation in Crohn's disease may be influenced by gender and ethnicity of the transmitting parent. Am J Gastroenterol. 93:(12):1998;2368-2372.
11. Grandbastien B., Peeters M., Franchimont D., Gower-Rousseau C., Speckel D., Rutgeerts P., Belaiche J., Cortot A., Vlietinck R., Colombel J.F. Anticipation in familial Crohn's disease. Gut. 42:(2):1998;170-174.
12. Hampe J., Schreiber S., Shaw S.H., Lau K.F., Bridger S., Macpherson A.J., Cardon L.R., Sakul H., Harris T.J., Buckler A., Hall J., Stokkers P., van Deventer S.J., Nurnberg P., Mirza M.M., Lee J.C., Lennard-Jones J.E., Mathew C.G., Curran M.E. A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort. Am J Hum Genet. 64:(3):1999;808-816.
13. Hugot J.P., Laurent-Puig P., Gower-Rousseau C., Olson J.M., Lee J.C., Beaugerie L., Naom I., Dupas J.L., Van Gossum A., Orholm M., Bonaiti-Pellie C., Weissenbach J., Mathew C.G., Lennard-Jones J.E., Cortot A., Colombel J.F., Thomas G. Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature. 379:(6568):1996;821-823.
14. Ohmen J.D., Yang H.Y., Yamamoto K.K., Zhao H.Y., Ma Y., Bentley L.G., Huang Z., Gerwehr S., Pressman S., McElree C., Targan S., Rotter J.I., Fischel-Ghodsian N. Susceptibility locus for inflammatory bowel disease on chromosome 16 has a role in Crohn's disease, but not in ulcerative colitis. Hum Mol Genet. 5:(10):1996;1679-1683.
15. Parkes M., Satsangi J., Lathrop G.M., Bell J.I., Jewell D.P. Susceptibility loci in inflammatory bowel disease. Lancet. 348:(9041):1996;1588.
16. Brant S.R., Fu Y., Fields C.T., Baltazar R., Ravenhill G., Pickles M.R., Rohal P.M., Mann J., Kirschner B.S., Jabs E.W., Bayless T.M., Hanauer S.B., Cho J.H. American families with Crohn's disease have strong evidence for linkage to chromosome 16 but not chromosome 12. Gastroenterology. 115:(5):1998;1056-1061.
17. Duerr R.H., Barmada M.M., Zhang L., Davis S., Preston R.A., Chensny L.J., Brown J.L., Ehrlich G.D., Weeks D.E., Aston C.E. Linkage and association between inflammatory bowel disease and a locus on chromosome 12. Am J Hum Genet. 63:(1):1998;95-100.
18. Curran M.E., Lau K.F., Hampe J., Schreiber S., Bridger S., Macpherson A.J., Cardon L.R., Sakul H., Harris T.J., Stokkers P., Van Deventer S.J., Mirza M., Raedler A., Kruis W., Meckler U., Theuer D., Herrmann T., Gionchetti P., Lee J., Mathew C., Lennard-Jones J. Genetic analysis of inflammatory bowel disease in a large European cohort supports linkage to chromosomes 12 and 16. Gastroenterology. 115:(5):1998;1066-1071.
19. Rioux J.D., Daly M.J., Green T., Stone V., Lander E.S., Hudson T.J., Steinhart A.H., Bull S., Cohen Z., Greenberg G., Griffiths A., McLeod R., Silverberg M., Williams C.N., Siminovitch K.A. Absence of linkage between inflammatory bowel disease and selected loci on chromosome 3, 7, 12, and 16. Gastroenterology. 115:(5):1998;1062-1065.
20. Ma Y., Ohmen J.D., Li Z., Bentley L.G., McElree C., Pressman S., Targan S.R., Fishel-Ghodsian N., Rotter J.I., Yang H. A genome-wide search identifies potential new susceptibility loci for Crohn's disease. Inflamm Bowel Dis. 5:(4):1999;271-278.
21. Mirza M.M., Lee J., Teare D., Hugot J.P., Laurent-Puig P., Colombel J.F., Hodgson S.N., Thomas G., Easton D.F., Lennard-Jones J.E., Mathew C.G. Evidence of linkage of the inflammatory bowel disease susceptibility locus on chromosome 16 (IBD1) to ulcerative colitis. J Med Genet. 35:(3):1998;218-221.
22. Heresbach D., Alizadeh M., Reumaux D., Colombel J.F., Delamaire M., Danze P.M., Gosselin M., Genetet B., Bretagne J.F., Semana G. Are HLA-DR or TAP genes genetic markers of severity in ulcerative colitis? J Autoimmun. 9:(6):1996;777-784.
23. De La Concha E.G., Fernandez-Arquero M., Santa Cruz S., Lopez-Nav G., Figueredo M.A., Diaz-Rubio M., Garcia-Paredes J. Positive and negative association of distinct HLA DR-2 subtypes with ulcerative colitis. Clin Exp Immunol. 108:1997;392-395.
24. Uyar F.A., Imeryuz N., Saruhan-Direskeneli G., Ceken H., Ozdogan O., Sahin S., Tozun N. The distribution of HLA-DRB alleles in ulcerative colitis patients in Turkey. Eur J Immunogenet. 25:(4):1998;293-296.
25. Bouma G., Crusius J.B., Garcia-Gonzalez M.A., Meijer B.U., Hellemans H.P., Hakvoort R.J., Schreuder G.M., Kostense P.J., Meuwissen S.G., Pena A.S. Genetic markers in clinically well defined patients with ulcerative colitis (UC). Clin Exp Immunol. 115:(2):1999;294-300.
26. Heresbach D., Alizadeh M., Bretagne J.F., Gautier A., Quillivic F., Lemarchand B., Gosselin M., Genetet B., Semana G. Investigation of the association of major histocompatibility complex genes, including HLA class I, class II and TAP genes, with clinical forms of Crohn's disease. Eur J Immunogenet. 23:(2):1996;141-151.
27. Reinshagen M., Loeliger C., Kuehnl P., Weiss U., Manfras B.J., Adler G., Boehm B.O. HLA class II gene frequencies in Crohn's disease: a population based analysis in Germany. Gut. 38:1996;538-542.
28. Bouma G., Poen A.C., Garcia-Gonzalez M.A., Schreuder G.M.T., Felt-Bersma R.J.F., Meuwissen S.G.M., Pena A.S. HLA-DRB1*03, but not the TNFα -308 promoter gene polymorphism, confers protection against fistulising Crohn's disease. Immunogenetics. 47:(6):1998;451-455.
29. Louis E., Franchimont D., Piron A., Gevaert Y., Schaaf-Lafontaine N., Roland S., Mahieu P., Malaise M., De Groote D., Louis R., Belaiche I. Tumour necrosis factor (TNF) gene polymorphism influences TNF-α production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol. 113:(3):1998;401-406.
30. Plevy S.E., Landers C.J., Prehn I., Carramanzana N.M., Deem R.L., Shealy D., Targan S.R. A role for TNF-α and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease. J Immunol. 159:(12):1997;6276-6282.
31. Louis E., Satsangi I., Roussomoustakaki M., Parkes M., Fanning G., Welsh K., Jewell D. Cytokine gene polymorphisms in inflammatory bowel disease. Gut. 39:(5):1996;705-710.
32. Farmer R.G., Hawk W.A., Turnbull R.B. Jr. Clinical patterns in Crohn's disease: a statistical study of 615 cases. Gastroenterology. 68:(4 Pt 1):1975;627-635.
33. Farmer R.G., Whelan G., Fazio V.W. Long-term follow-up of patients with Crohn's disease. Relationship between the clinical pattern and prognosis. Gastroenterology. 88:(6):1985;1818-1825.
34. De Dombal F.T., Burton I., Goligher J.C. Recurrence of Crohn's disease after primary excisional surgery. Gut. 12:(7):1971;519-527.
35. Greenstein A.J., Lachman P., Sachar D.B., Springhorn J., Heimann T., Janowitz H.D., Aufses A.H. Jr. Perforating and non-perforating indications for repeated operations in Crohn's disease: evidence for two clinical forms. Gut. 29:(5):1988;588-592.
36. Sachar D.B., Andrews H.A., Farmer R.G., et al. Proposed classification of patients subgroups in Crohn's disease. Gastroenterol Int. 5:1992;141-154.
37. Musso A., Fiorentini M.T., Sostegni R., Sambataro A., Balzola F., Astegiano M., Pera A. Subgroup classification in Crohn's disease: treatment and outcome in long-term follow-up. Gastroenterology. 106:1994;A742.
38. Gasche C., Scholmerich J., Brynskov J., D'Haens G., Hanauer S.B., Irvine E.J., Jewell D.P., Rachmilewitz D., Sachar D.B., Sandborn W.J., Sutherland L.R. A simple classification of Crohn's disease: Report of the working party for the World Congress of Gastroenterology, Vienna 1998. Inflamm Bowel Dis. 6:(1):2000;8-15.
39. Rocca G, Trapani A, Astegiano M, Laudi C, Sostegni R, Daperno M, Musso A, Bresso F, Pera A, Rizzetto M. Differentiation and subgrouping of Crohn's disease. In: Rogler G, Rutgeerts P, Sartor RB, Scholmerich J, editors. IBD at the end of its First Century, Dordrecht: Kluwer Academic Publisher, 2000, pp. 165-72, chapter 18.
40. Bresci G., Parisi G., Gambardella L., Banti S., Bertoni M., Rindi G., Capria A. Evaluation of clinical patterns in ulcerative colitis: a long-term follow-up. Int J Clin Pharmacol Res. 17:(1):1997;17-22.
41. Samuelsson S.M., Ekbom A., Zack M., Helmick C.G., Adami H.O. Risk factors for extensive ulcerative colitis and ulcerative proctitis: a population based case-control study. Gut. 32:(12):1991;1526-1530.
42. Griffin M.G., Miner P.B. Review article: refractory distal colitis - explanations and options. Aliment Pharmacol Ther. 10:(1):1996;39-48.
43. Langholz E., Munkholm P., Davidsen M., Binder V. Course of ulcerative colitis: analysis of changes in disease activity over years. Gastroenterology. 107:(1):1994;3-11.
44. Vecchi M., Gionchetti P., Bianchi M.B., Belluzzi A., Meucci G., Campieri M., de Franchis R. p-ANCA and development of pouchitis in ulcerative colitis patients after proctocolectomy and ileoanal pouch anastomosis. Lancet. 344:(8926):1994;886-887.
45. Sandborn W.J., Landers C.J., Tremaine W.J., Targan S.R. Association of antineutrophil cytoplasmic antibodies with resistance to treatment of left-sided ulcerative colitis: results of a pilot study. Mayo Clin Proc. 71:(5):1996;431-436.
46. Claise C., Johanet C., Bouhnik Y., Kapel N., Homberg J.C., Poupon R. Antineutrophil cytoplasmic autoantibodies in autoimmune liver and inflammatory bowel diseases. Liver. 16:(1):1996;28-34.
47. Bansi D.S., Chapman R.W., Fleming K.A. Prevalence and diagnostic role of antineutrophil cytoplasmic antibodies in inflammatory bowel disease. Eur J Gastroenterol Hepatol. 8:(9):1996;881-885.
48. Roozendaal C., Kallenberg C.G. Anti-neutrophil cytoplasm autoantibodies (ANCA) in autoimmune liver diseases. Hepatogastroenterology. 46:(30):1999;3034-3040.
49. Quinton J.F., Sendid B., Reumaux D., Duthilleul P., Cortot A., Grandbastien B., Charrier G., Targan S.R., Colombel J.F., Poulain D. Anti-saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut. 42:(6):1998;788-791.